Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Purigen Biosystems Inc. currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 2 distinct examiners, though they are concentrated within 1 distinct art unit. This concentration suggests a focused prosecution strategy within a specific regulatory niche at the patent office. Practitioners should note that while the technology area is broad, the current filings are being evaluated by a very limited number of internal groups.
The busiest examiner for the portfolio is WRIGHT, PATRICIA KATHRYN, who is responsible for 1 pending office action. Because the total number of pending actions is 2, no single examiner handles the majority of the active workload. This distribution across 2 distinct examiners may require the applicant to monitor different examination styles even within a single art unit. The presence of 1 distinct art unit indicates that the legal team can likely reuse certain technical arguments or prior art citations across the pending cases.
With the current pending office actions, the administrative burden is relatively low, allowing for a high degree of attention to each response. The involvement of 2 distinct examiners means that the company's success is not entirely dependent on the discretion of a single individual. However, the fact that all 2 pending actions fall under the same art unit implies that the examiners likely share a common supervisory chain and similar interpretations of patentability guidelines in the biotechnology sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WRIGHT, PATRICIA KATHRYN | 1 | 65.3% | +42.6% |
| BOWERS, ERIN M | 1 | 54.7% | +10.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18706989 | Fluidic Device With Capillary Barrier | WRIGHT, PATRICIA KATHRYN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18212882 | Lysis Buffers Comprising Cyanate or Thiocyanate and a Detergent | BOWERS, ERIN M | 47d |
| 18706989 | Fluidic Device With Capillary Barrier | WRIGHT, PATRICIA KATHRYN | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18706989 | Fluidic Device With Capillary Barrier | WRIGHT, PATRICIA KATHRYN | — | §102§112 | Non-Final OA | — | Pending | May 02, 2024 |
| 18212882 | Lysis Buffers Comprising Cyanate or Thiocyanate and a Detergent | BOWERS, ERIN M | 1653 | §103 | Final Rejection | 47d | Pending | Jun 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial